Clinical Trial Update: Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating epratuzumab for Non-Hodgkin lymphoma; current status/details are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Epratuzumab (epratuzumab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lymphoma | Phase 3 | Status: UNKNOWN